Daniel D Billadeau

Ut Southwestern Medical Center

$13,701,310

Attributed

$17,250,877

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.4M · FY2005–25

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$26,191,578 · 12

By mechanism

R01$12,503,856 · 5

P50$11,755,761 · 3

T32$1,097,211 · 1

R21$437,250 · 1

R56$397,500 · 1

P20$0 · 1

Top collaborators

Most similar at Ut Southwestern Medical Center

Same institution · by research overlap

Ezra Burstein$12,330,597

Others in their field

Top investigators on “Proteins”

David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
Randall J Bateman · Washington University$187,292,085
Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
Reisa A. Sperling · Banner Health$145,046,481
Barton F Haynes · Duke University$136,029,850
Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280

Research focus

ProteinsRegulationMolecularMediatingReceptorPlayActinsSignal PathwayComplexSignal TransductionPublishingIn VivoPathway InteractionsBaseGenesInsightGenerationsEventCell PhysiologyLeadTumorFamilyBindingResearch Study

Grant awards (61)

Molecular mechanism of EGFRs protein-protein interaction inhibition by a grafted peptide in NSCLC$339,816

R01 · FY2025 · CA

NIDDK Multidisciplinary Predoctoral Training in Discovery and Translational Research$269,505

T32 · FY2025 · DK

Regulation of Nutrient Homeostasis by COMMD proteins$414,058

R01 · FY2024 · DK

Molecular mechanism of EGFRs protein-protein interaction inhibition by a grafted peptide in NSCLC$328,309

R01 · FY2024 · CA

NIDDK Multidisciplinary Predoctoral Training in Discovery and Translational Research$217,287

T32 · FY2024 · DK

Regulation of Nutrient Homeostasis by COMMD proteins$434,128

R01 · FY2023 · DK

Molecular mechanism of EGFRs protein-protein interaction inhibition by a grafted peptide in NSCLC$333,654

R01 · FY2023 · CA

NIDDK Multidisciplinary Predoctoral Training in Discovery and Translational Research$204,340

T32 · FY2023 · DK

Molecular mechanism of EGFRs protein-protein interaction inhibition by a grafted peptide in NSCLC$16,384

R01 · FY2023 · CA

Regulation of Nutrient Homeostasis by COMMD proteins$439,255

R01 · FY2022 · DK

Molecular mechanism of EGFRs protein-protein interaction inhibition by a grafted peptide in NSCLC$323,057

R01 · FY2022 · CA

NIDDK Multidisciplinary Predoctoral Training in Discovery and Translational Research$209,118

T32 · FY2022 · DK

Regulation of Nutrient Homeostasis by COMMD proteins$439,034

R01 · FY2021 · DK

Molecular mechanism of EGFRs protein-protein interaction inhibition by a grafted peptide in NSCLC$329,651

R01 · FY2021 · CA

NIDDK Multidisciplinary Predoctoral Training in Discovery and Translational Research$99,038

T32 · FY2021 · DK

Regulation of Copper Homeostasis by COMMD proteins$424,724

R01 · FY2020 · DK

Mechanisms Regulating Human NK Cell Cytotoxicity$397,500

R01 · FY2020 · AI · contact PI

NIDDK Multidisciplinary Predoctoral Training in Discovery and Translational Research$97,923

T32 · FY2020 · DK

Regulation of Copper Homeostasis by COMMD proteins$428,303

R01 · FY2019 · DK

Mechanisms Regulating Human NK Cell Cytotoxicity$397,500

R01 · FY2019 · AI · contact PI

Mayo Clinic SPORE in Pancreatic Cancer$2,297,971

P50 · FY2018 · CA

Regulation of Copper Homeostasis by COMMD proteins$431,731

R01 · FY2018 · DK

Mechanisms Regulating Human NK Cell Cytotoxicity$397,500

R01 · FY2018 · AI · contact PI

NFAT Transcription Factors as Therapeutic Targets in Pancreatic Cancer$302,818

P50 · FY2018 · CA · contact PI

Mayo Clinic SPORE in Pancreatic Cancer$2,300,000

P50 · FY2017 · CA

Regulation of Copper Homeostasis by COMMD proteins$435,034

R01 · FY2017 · DK

Mechanisms Regulating Human NK Cell Cytotoxicity$397,500

R01 · FY2017 · AI · contact PI

NFAT Transcription Factors as Therapeutic Targets in Pancreatic Cancer$267,478

P50 · FY2017 · CA · contact PI

Mayo Clinic SPORE in Pancreatic Cancer$2,157,728

P50 · FY2016 · CA

Regulation of Copper Homeostasis by COMMD proteins$447,535

R01 · FY2016 · DK

Mechanisms Regulating Human NK Cell Cytotoxicity$397,500

R01 · FY2016 · AI · contact PI

NFAT Transcription Factors as Therapeutic Targets in Pancreatic Cancer$284,183

P50 · FY2016 · CA · contact PI

Mayo Clinic SPORE in Pancreatic Cancer$2,185,002

P50 · FY2015 · CA

NFAT Transcription Factors as Therapeutic Targets in Pancreatic Cancer$287,776

P50 · FY2015 · CA · contact PI

Regulation of NK Cell Activation by DOCK8-Mediated Pathways$397,500

R56 · FY2014 · AI · contact PI

Regulation of Actin Dynamics During T Cell Activation$351,277

R01 · FY2014 · AI · contact PI

NFAT Transcription Factors as Therapeutic Targets in Pancreatic Cancer$284,103

P50 · FY2014 · CA · contact PI

The Role of COTL1 in T cell development and activation$198,750

R21 · FY2014 · AI

Regulation of Actin Dynamics During T Cell Activation$330,200

R01 · FY2013 · AI · contact PI

The Role of COTL1 in T cell development and activation$238,500

R21 · FY2013 · AI

P-1: Regulation of Pancreatic Cancer Cell Production and Survival by GSK-3B$128,024

P50 · FY2013 · CA · contact PI

Regulation of Actin Dynamics During T Cell Activation$351,277

R01 · FY2012 · AI · contact PI

Mechanisms of Natural Killer Cell Activation$302,744

R01 · FY2012 · CA · contact PI

P-1: Regulation of Pancreatic Cancer Cell Production and Survival by GSK-3B$269,805

P50 · FY2012 · CA · contact PI

Regulation of Actin Dynamics During T Cell Activation$351,277

R01 · FY2011 · AI · contact PI

Mechanisms of Natural Killer Cell Activation$302,744

R01 · FY2011 · CA · contact PI

P-1: Regulation of Pancreatic Cancer Cell Production and Survival by GSK-3B$256,805

P50 · FY2011 · CA · contact PI

Regulation of Actin Dynamics During T Cell Activation$354,825

R01 · FY2010 · AI · contact PI

Mechanisms of Natural Killer Cell Activation$312,108

R01 · FY2010 · CA · contact PI

P-1: Regulation of Pancreatic Cancer Cell Production and Survival by GSK-3B$269,917

P50 · FY2010 · CA · contact PI

Mechanisms of Natural Killer Cell Activation$312,108

R01 · FY2009 · CA · contact PI

Regulation of Actin Dynamics During T Cell Activation$277,189

R01 · FY2009 · AI · contact PI

P-1: Regulation of Pancreatic Cancer Cell Production and Survival by GSK-3B$271,033

P50 · FY2009 · CA · contact PI

Mechanisms of Natural Killer Cell Activation$312,108

R01 · FY2008 · CA · contact PI

Regulation of Actin Dynamics During T Cell Activation$277,189

R01 · FY2008 · AI · contact PI

P-1: Regulation of Pancreatic Cancer Cell Production and Survival by GSK-3B$193,118

P50 · FY2008 · CA · contact PI

Mechanisms of Natural Killer Cell Activation$289,782

R01 · FY2007 · CA · contact PI

Regulation of Actin Dynamics During T Cell Activation$282,558

R01 · FY2007 · AI · contact PI

Regulation of Actin Dynamics During T Cell Activation$290,997

R01 · FY2006 · AI · contact PI

Regulation of Actin Dynamics During T Cell Activation$253,300

R01 · FY2005 · AI

Role of Vav1 protooncogene in pancreatic cancer$0

P20 · FY2003 · CA